Legal Representation
Attorney
Michael P. Matesky, II
USPTO Deadlines
Application History
20 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 5, 2025 | CORN | I | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED | Loading... |
| Apr 22, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Apr 22, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Apr 22, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Apr 21, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Apr 21, 2025 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Apr 21, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Apr 21, 2025 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Apr 21, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Dec 13, 2024 | CRCV | M | CORRECTION TRANSACTION RECEIVED FROM IB | Loading... |
| Nov 17, 2024 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Oct 23, 2024 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Oct 23, 2024 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Oct 15, 2024 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Oct 15, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 15, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Aug 30, 2024 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Aug 30, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 29, 2024 | LIMI | I | LIMITATION FROM ORIGINAL APPLICATION ENTERED | Loading... |
| Aug 15, 2024 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of neurological, renal, hematopoietic diseases; pharmaceuticals, namely, pharmaceutical products for treating respiratory diseases; chemical preparations for pharmaceutical purposes, namely, for the treatment of neurological, renal, hematopoietic, respiratory diseases or disorders
Additional Information
Design Mark
The mark consists of the wording "VEEPRHO" placed inside an oval in blue on a black background. There is a thin white outline of an oval just inside the blue oval. The wording "VEEPRHO" is in white and its front stylized letter "V" contains a graphic of a molecule of three atoms in various shades of green.
Color Claim
The color(s) blue, green, white and black is/are claimed as a feature of the mark.
Classification
International Classes
005